Respiratory Infections News

Among patients with COVID-19, those who had hypertension or type 2 diabetes were more likely to develop neurological conditions associated with the infectious disease, data from a small study show.

The FDA announced it has issued emergency use authorization for the Lucira COVID-19 All-In-One Test Kit, a molecular, single-use test that can be used at home and provides results in 30 minutes or less.

Pfizer and BioNTech said they are “within days” of submitting their COVID-19 vaccine candidate to the FDA for an emergency use authorization after meeting a required safety milestone.

Globally, millions of people affected by tuberculosis are being diagnosed and treated with outdated tools, according to a new report from the Stop TB Partnership.

An artificial intelligence voice analysis tool can help diagnose COVID-19 in asymptomatic patients, according to its manufacturer, Vocalis Health.

More than 1 million children in the United States have been diagnosed with COVID-19, according to the AAP, which is tracking data reported by state health departments.

An interim review of phase 3 data showed that a COVID-19 vaccine codeveloped by Moderna Inc. and the NIH had an efficacy rate of 94.5% with no significant safety concerns, Moderna said.

Epidemiologic evidence indicates that a broken sewage pipe might have been the cause of a small outbreak of COVID-19 in a Chinese city, researchers recently reported.

Just like in adult patients, ART reduces the risk that children with HIV will get or die from tuberculosis, according to data from six African countries.

Other respiratory viral infections, including influenza, have declined significantly at a Connecticut hospital during the COVID-19 pandemic, according to a study published in Open Forum Infectious Diseases.